Latest News and Press Releases

HANGZHOU, China, March 30, 2026 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider and crypto...

Intersection includes 23.9m of 1.72 g/t gold, 7.15m of 3.46 g/t gold, and 16m of 0.07 g/t gold* Exploration further expands gold mineralization at Juby Gold Project on Golden Lake Deposit TORONTO,...

AskNicely launches Ask NiceAI, turning customer feedback into instant insights and action plans to help businesses improve CX and drive growth.

- Written FDA recommendations include a second Phase 3 trial to generate additional efficacy and safety data prior to NDA submission of brilaroxazine for schizophrenia – - Current data package...

HIGHLIGHTS:  174,000 meters of exploration and grade control drilling conducted in 2025, with 36% directed towards the Koné and Gbongogo Main deposits, in addition to delineating new higher-grade...

TORONTO, March 28, 2026 (GLOBE NEWSWIRE) -- (TSX: SPFD) Mulvihill Enhanced Split Preferred Share ETF (the “Fund”) (formerly Mulvihill U.S. Health Care Enhanced Yield ETF) announces results of...

TORONTO, March 28, 2026 (GLOBE NEWSWIRE) -- (TSX: PGIC; PGIC.PR.A)  (the “Fund”) announces results of operations for the year ended December 31, 2025. Increase in net assets attributable to holders...

AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session Across the COAST 1, COAST 2, and SHORE phase 3 studies, amlitelimab, dosed...

AAD : Sanofi présente de nouveaux résultats de phase 3 pour l'amlitelimab dans la dermatite atopique lors d'une session de dernière minute Dans les études de phase 3 COAST 1, COAST 2 et SHORE,...

Phoenix, AZ, March 27, 2026 (GLOBE NEWSWIRE) -- MidPoint Capital Partners, LLC announced the launch of a $500 million private real estate lending fund, MidPoint Capital, LLC, designed to provide...